https://www.selleckchem.com/products/t0901317.html
Others showed significant improvement in treatment response only among Whites, including variation in DTNBP1, DRD4, and GNB3. Conclusions The current analysis can help tailor management among Blacks using an atypical antipsychotic. Heterogeneity in genetic variation effects and response allele frequency suggests that pharmacogenetics approaches for atypical antipsychotics will need to explicitly incorporate race and ethnicity. Copyright © 2020, Ethnicity Disease, Inc.Precision medicine research designed to reduce health dispariti
Like
Comment
Share
